Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan 3;14(1):106.
doi: 10.3390/diagnostics14010106.

The Genetic Landscape of Sleep Disorders in Parkinson's Disease

Affiliations
Review

The Genetic Landscape of Sleep Disorders in Parkinson's Disease

Kallirhoe Kalinderi et al. Diagnostics (Basel). .

Abstract

Parknson's disease (PD) is the second most common neurodegenerative disease, affecting 1% of people aged over 60. PD is characterized by a wide range of motor symptoms, however the clinical spectrum of PD covers a wide range of non-motor symptoms, as well. Sleep disorders are among the most common non-motor symptoms of PD, can occur at any stage of the disease and significantly affect quality of life. These include rapid eye movement sleep behavior disorder (RBD), restless legs syndrome (RLS), excessive daytime sleepiness (EDS), insomnia, obstructive sleep apnea (OSA) and circadian rhythm disturbances. One of the main challenges in PD research is identifying individuals during the prodromal phase of the disease. Combining genetic and prodromal data may aid the early identification of individuals susceptible to PD. This review highlights current data regarding the genetic component of sleep disorders in PD patients, focusing on genes that have currently been associated with this PD co-morbidity.

Keywords: GBA; Parkin; Parkinson’s disease; sleep disorders.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Scheme 1
Scheme 1
Genes and sleep disorders in PD.

Similar articles

Cited by

References

    1. de Lau L., Breteler M. Epidemiology of Parkinson’s disease. Lancet Neurol. 2006;5:525–535. doi: 10.1016/S1474-4422(06)70471-9. - DOI - PubMed
    1. Kalinderi K., Bostantjopoulou S., Fidani L. The genetic background of Parkinson’s disease: Current progress and future prospects. Acta. Neurol. Scand. 2016;134:314–326. doi: 10.1111/ane.12563. - DOI - PubMed
    1. Thangaleela S., Sivamaruthi B.S., Kesika P., Mariappan S., Rashmi S., Choeisoongnern T., Sittiprapaporn P., Chaiyasut C. Neurological Insights into Sleep Disorders in Parkinson’s Disease. Brain Sci. 2023;13:1202. doi: 10.3390/brainsci13081202. - DOI - PMC - PubMed
    1. Riboldi G.M., Di Fonzo A.B. GBA, Gaucher Disease, and Parkinson’s Disease: From Genetic to Clinic to New Therapeutic Approaches. Cells. 2019;8:364. doi: 10.3390/cells8040364. - DOI - PMC - PubMed
    1. Gan-Or Z., Amshalom I., Kilarski L.L., Bar-Shira A., Gana-Weisz M., Mirelman A., Marder K., Bressman S., Giladi N., Orr-Urtreger A. Differential effects of severe vs mild GBA mutations on Parkinson disease. Neurology. 2015;84:880–887. doi: 10.1212/WNL.0000000000001315. - DOI - PMC - PubMed

LinkOut - more resources